Clinical trial
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
NCT00420810 · H. Lundbeck A/S, Industry · Terminated
Key facts
| NCT number | NCT00420810 |
|---|---|
| Title | Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED) |
| Official title | A Double-Blind, Placebo Controlled, Randomized, Cross-Over Polysomnographic Study of MK0928 15 mg in Adult Patients With Primary Insomnia |
| Lead sponsor | H. Lundbeck A/S, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Primary Insomnia |
| Intervention type | Drug |
| Interventions | MK0928 / Duration of Treatment : 8 Weeks |
| Enrollment | 138 |
| Start date | Sep 1, 2006 |
| Primary completion | Mar 1, 2007 |
| First posted | Jan 11, 2007 |
| Last update posted | Jan 14, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: